We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations


Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

GM AHSN's Innovation Nexus makes shortlist for 15th annual Bionow Awards

The outstanding Northern life science and biomedical companies and projects of 2016 have been announced on a shortlist for the annual Bionow Awards, which take place on November 24. 

GM AHSN's Innovation Nexus - an advice portal for innovators wishing to work with the NHS - has been shortlisted for the Bionow Business Services Award.

These prestigious awards, recognising the excellence, enterprise and endeavour of the North’s life sciences sector, are sponsored by Manchester Science Partnerships, the UK’s largest science and technology park operator. 

The event showcases the strength, depth and talent of businesses and individuals based in the North and recognises best in class achievement across 10 categories. Winners will be announced at a black tie dinner at the Mere Golf Resort and Spa, Cheshire. 

Dr Linda Magee, GM AHSN's Executive Director, Industry & Wealth, said:


"We are delighted to be shortlisted in the Bionow awards. The bio health industry is a very important partner in our mission to deliver needs-led innovation to the market for patient benefit and, in so doing, support business growth." 

Dr Geoff Davison, chief executive of Bionow, the not-for-profit membership organisation for the biomedical / life-sciences industry in the North said:

“Life science is one of the genuine strengths of the North of England economy and our short list represents an impressive array of dynamic, innovation-based companies and remarkable individuals. They are the leaders responsible for the innovation and world class science that flows from our region.” 

Dr Chris Doherty, managing director of Alderley Park, Cheshire, the UK’s largest dedicated bio campus life science facility, which is part of Manchester Science Partnerships said:

“The shortlist overflows with inspiring businesses and people. Despite a year of momentous political upheaval in the country as a whole, the life sector in the North has held its own and shown the way, flying the flag for UK PLC. Many of these helped Manchester make a great success of its year as European City of science and the North as a whole worked well together on a Northern Powerhouse trade mission to the USA. We are delighted to support the Bionow awards as the organisation itself plays a vital role in lobbying for investment and raising important issues.” 

The categories and shortlisted entries are: 

Bionow Start Up of the Year Award - Sponsored by RSM 
  • Aptus Clinical is a specialist contract clinical resource provider that supports biopharma clients with the design, conduct and delivery of early phase clinical studies with a particular focus in oncology 
  • Manchester Imaging is a dental diagnostic software business. Our platform technology underpins an image analysis portfolio with applications in several aspects of dental healthcare. Our applications will help dentists empower patients to look after their teeth more effectively, reducing the need for restorations and repairs, saving insurance companies and governments money 
  • Microbiosensor has developed three inexpensive point of care diagnostic devices for microbial infections. Its lead product PD-Safe, will enter formal clinical trials in 2017, with a CE mark expected 2018. The products offer NHS cost savings, improved care for vulnerable patient groups and to mitigate against growing antimicrobial resistance

Bionow Healthcare Project of the Year Award - Sponsored by TRUSTECH 
  • Imagen Therapeutics. The personalization of ovarian Chemotherapy using Phenotypic High Content Screening
  • Microbiosensor. InfectDetect: a novel antimicrobial susceptibility detector to reduce A&E admissions
  • University of Leeds/Pd-m International. The Intra-Abdominal Platform (IAP) for enhanced laparoscopic surgery

Bionow Project of the Year Award - Sponsored by Waters Corporation 
  • Cobra Biologics. Scalable AAV Production using Novel Hollow Fibre Bioreactors
  • Redx Pharma plc. Development of reversible Bruton’s Tyrosine Kinase (BTK) Inhibitors
  • University of Manchester. Development of a novel infected soft tissue wound model 

Bionow Product of the Year Award - Sponsored by Innovation Agency 
  • Elucigene Diagnostics. CF-EU2
  • Magnesium Elektron. Elektron SynerMag® - Bioresorbable Magnesium Implant Alloy
  • Shield Therapeutics plc. Feraccru® for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease

Bionow Technical Service Award - Sponsored by Appleyard Lees 
  • Magnesium Elektron. Elektron SynerMag® - Bioresorbable Magnesium Implant Alloy
  • Perfectus Biomed. Customised microbiology specialising in biofilm based antimicrobial testing
  • University of Liverpool. Liverpool Bio-Innovation Hub (LBIH) Biobank


Bionow Business Services Award - Sponsored by Skills and Growth Company 
  • Greater Manchester Academic Health Science Network. Innovation Nexus
  • Integral Finance. Finance partnering and business valuation service
  • Slater Heelis LLP. Legal Services

Bionow Promising Technologist of the Year Award - Sponsored by Seqiris 
  • Amy Cooke, Redx Pharma plc 
  • Bianca Price, University of Manchester
  • Louise Almond, Allergan Biologics 

Bionow Investment Deal of the Year Award - Sponsored by QIAGEN 
  • Evgen Pharma plc. Evgen Pharma: Back-to-back pre-IPO and IPO (and Admission to AIM) 
  • F2G. F2G’s $60 million Financing Round
  • Shield Therapeutics plc. Successful completion of an Initial Public Offering on LSE-AIM

Bionow Outstanding Contribution Award - Sponsored by Sci-Tech Daresbury 
  • To be announced on the night. 

Bionow Company of the Year Award - Sponsored by AstraZeneca 
  • Advanced Medical Solutions Group plc is a leading company in the development and manufacture of products for the $15 billion global wound care market. Its headquarters are in Winsford, Cheshire
  • F2G is an established Manchester-based specialist antifungal company developing a completely new class of antifungal agents to treat life threatening invasive fungal infections
  • Shield Therapeutics plc. Since formation, Shield Therapeutics plc has been an innovative and entrepreneurial specialty pharmaceutical company that provides solutions to unmet medical needs


The Bionow Awards Dinner is also sponsored by Appleyard Lees, CY Partners, Redx Pharma and World Courier.